FBInvestor
Stocks / Edesa Biotech Inc
Institutional Ownership

Edesa Biotech Inc

CUSIP 27966L306COM NEWEDSAQ1 2026

13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
25
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

14 filings · latest Mar 3, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Mar 3, 2026Point72 Asset Management, L.P.13G7.2%600.0KSEC
2Mar 2, 2026Pardeep Nijhawan Medicine Professional Corporation13D/A20.0%—SEC
3Mar 2, 2026Velan Capital Master Fund LP13D/A10.0%—SEC
4Feb 13, 2026Nantahala Capital Management, LLC13G/A10.0%855.6KSEC
5May 15, 2025Nantahala Capital Management, LLC13G10.0%700.5KSEC
6Feb 25, 2025Stonepine Capital Management, LLC13G9.9%—SEC
7Feb 18, 2025Thomas A. Satterfield, Jr.13G/A11.0%9SEC
8Feb 18, 2025Velan Capital Master Fund LP13D10.0%—SEC
9Feb 14, 2025Pardeep Nijhawan Medicine Professional Corporation13D/A20.0%—SEC
10Feb 12, 2025Thomas A. Satterfield, Jr.13G/A11.0%232.2KSEC

4 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Edesa Biotech Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Velan Capital Investment Management LP827.5K$4.33M
2Rubric Capital Management LP687.5K$3.60M
3Perceptive Advisors LLC563.2K$2.95M
4Jane Street Group, LLC115.7K$605.2K
5Geode Capital Management, LLC77.1K$403.0K
6State Street Corp38.0K$198.6K
7Commonwealth Equity Services, LLC35.0K$183.1K
8Scientech Research LLC30.5K$159.7K
9Stonepine Capital Management, LLC30.0K$156.9K
10Blackrock, Inc.27.7K$144.9K